Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: Results from long-term follow-up of the Occluded Artery Trial (OAT) cohort

American Heart Journal

Volumn 163, Issue 4, 2012, Pages 563-571

  White, Harvey D ^a   Reynolds, Harmony R ^b   Carvalho, Antonio C ^c   Pearte, Camille A ^b   Liu, Li ^d   Martin, C Edwin ^e   Knatterud, Genell L ^f   Džavík, Vladimír ^g   Kruk, Mariusz ^h   Steg, Philippe Gabriel ⁱ   Cantor, Warren J ^j   Menon, Venu ^k   Lamas, Gervasio A ^l   Hochman, Judith S ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Clinical Trials & Surveys Corp   (United States)

^e YORK HOSPITAL   (United States)

^f MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h INSTITUTE OF CARDIOLOGY   (Poland)

ⁱ BICHAT HOSPITAL   (France)

^j SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^k LERNER RESEARCH INSTITUTE   (United States)

^l MOUNT SINAI MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; Q WAVE; STENT THROMBOSIS; SUDDEN DEATH;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RECURRENCE;

EID: 84860165900     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.01.016     Document Type: Article

References (21)

1. J.S. Hochman, G.A. Lamas, and C.E. Buller Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 355 2006 2395 2407
2. J.S. Hochman, H.R. Reynolds, and V. Dzavik Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction Circulation 124 2011 2320 2328
3. J.S. Hochman, G.A. Lamas, and G.L. Knatterud Design and methodology of the Occluded Artery Trial (OAT) Am Heart J 150 2005 627 642
4. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
5. J.S. Hochman, H.R. Reynolds, and V. Dzavik Persistent lack of benefit of late revascularization of the occluded coronary artery post-MI-the Occluded Artery Trial (OAT) long term results Circulation 122 2010 A13116
6. S. Yusuf, F. Zhao, and S.R. Mehta Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
7. S.R. Steinhubl, P.B. Berger, and J.T. Mann Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
8. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
9. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observation J Am Stat Assoc 53 1958 457 481
10. R. Peto, M.C. Pike, and P. Armitage Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples Br J Cancer 35 1977 1 39
11. D.R. Cox Regression models of life tables (with discussion) J R Stat Soc [Ser A] B34 1972 187 220
12. M.J. Pencina, and R.B. D'Agostino Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation Stat Med 23 2004 2109 2123
13. K. Huber, H.R. Reynolds, and V. Dzavik Effects of reinfarction on mortality in patients with recanalized or conservatively treated occluded coronary arteries in the occluded artery trial (OAT) Eur Heart J 29 2008 71 P600
14. J.E. Udelson, C.A. Pearte, and C.D. Kimmelstiel The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention vs. optimal medical therapy alone Am Heart J 161 2011 611 621
15. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
16. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
17. I. Porto, J.B. Selvanayagam, and W.J. Van Gaal Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound Circulation 114 2006 662 669
18. G.S. Werner, B.M. Richartz, and O. Gastmann Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions Circulation 102 2000 2959 2965
19. G.S. Werner, R. Surber, and M. Ferrari The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction Eur Heart J 27 2006 2406 2412
20. V. Dzavik, C.E. Buller, and G.A. Lamas Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 Trial Circulation 114 2006 2449 2457
21. P.G. Steg, A. Kerner, and G.B. Mancini Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trial Circulation 121 2010 2724 2730